Whilst previously rare, some surveys indicate substantial increases in the population with body mass index (BMI) ≥40 kg/m 2 since the 1980s. Clinicians report emerging care challenges for this population, often with high resource demands. Accurate prevalence data, gathered using reliable methods, are needed to inform health care practice, planning, and research. We searched digitally for English language sources with measured prevalence data on adult BMI ≥40 collected since 2010. The search strategy included sources identified from recent work by NCD-RisC (2017), grey sources, a literature search to find current sources, and digital snowball searching.
due to lack of awareness and limited evidence base. This problem is compounded by stigmatization over size and weight by the media, within society and among health professionals. 17 Furthermore, conventional behavioural weight management interventions have minimal impact for BMI ≥40. 18 Only a minority of individuals access bariatric surgery, 19 and effective nonsurgical interventions are not yet widely available. 20 Thus, once individuals reach a very high BMI, the potential for sustained weight loss to improve quality of life and reduce secondary medical complications is limited.
The severity and impact of muscular-skeletal complications reduce physical activity and mobility, increasing dependence on others and putting weight loss further out of reach. Consequently, individuals with BMI ≥40 face reduced life expectancy, 21 multimorbidity, 22 disability, 23 and reduced quality of life. 24 In turn, this disease burden produces multifaceted demands on health and social care services, raising direct and indirect costs. 25 Until recently, evidence on direct costs of BMI ≥40 have been limited. 25 Total health care costs in the United Kingdom rise linearly, and double, as BMI increases 26 from 20 to 40. A recent systematic review of international health care costs and BMI found costs for people with BMI ≥40 to be 50% greater than for people with BMI 18.5 to 24.9. 27 Costing studies typically exclude underresearched wider care costs, such as social care 28 and nursing home usage related to functional disability and often long-term provision, 28, 29 so current estimates are likely to underestimate the full costs. Forecasts indicate that increased resource usage will continue, including costs required to structurally adapt care facilities to the needs of people with BMI ≥40, alongside providing suitable equipment and training for staff, that is currently missing. 30 The present scoping review explores the extent of international prevalence data on BMI ≥40. It focusses on measured data, given the potential for error and bias with self-reported anthropometry by individuals who are overweight. 31, 32 We assessed the extent and quality of epidemiological reporting for the BMI ≥40 category internationally, with a view to improving the documentation of this emerging highdemand population in future national surveys, to enable development of a reliable evidence base to guide effective care.
| METHODS
The primary epidemiological reports being investigated are health surveys, undertaken by governments for population surveillance to inform strategic policy priorities. Health surveys are not usually reported in the academic literature, unless for a secondary analysis focussed on a specific issue or subpopulation, often with considerable time lag. Thus, database search terms for the primary survey would need to be very broad, making identification through academic databases highly resource intensive, with results prone to being incomplete and outdated. For the present scoping review, an alternative search strategy was therefore applied, based on the sources identified by the most recent systematic review of international BMI survey data, with additional searches to update and supplement these sources, outlined below.
Four key approaches were used to identify potential data sources:
Building on previous work
The NCD Risk Factor Collaboration (NCD-RisC) 2017 study on global BMI trends was chosen as a basis for the initial search, on the basis of its size and rigour: It used 2416 sources of measured data, collected up to 2016. 33 These sources were compiled from a systematic medical database search, supplemented by a worldwide network of researchers identifying and accessing national measurement surveys via interested parties, including World Health Organization (WHO). Full details are given in the published paper and its appendix. 33 All 2416 sources in the NCD-RisC appendix were screened as per the inclusion criteria in Table 1 in Appendix A. Results from conference proceedings were deliberately included, as they can provide the first exposure of research analysis, highlighting new or updated data sources, whilst full articles commonly take much longer to publication, if indeed they are ever published in full. Sources were searched both for BMI ≥40 data, but also to identify any new sources/health surveys not already located through parts 1 and 2 of the search process.
Digital snowball searching
Whilst NCD-RisC identified sources, individual sources needed located and accessed, often directly from a website of government agencies or international bodies. This was undertaken digitally, seeking previously unknown sources or articles.
All sources were screened using inclusion criteria in Table 1 . ized surveys were identified, sources were checked for the most current data, with the most recent data retained. If multiple studies for the same country or source were identified, the one with the largest sample, or that provided the most information to data extraction, was retained. These pragmatic methods adopt a systematic approach to exploring the broad evidence landscape in an emerging area, highlighting gaps for future, more detailed research. 34 
| RESULTS
Prevalence data of measured BMI ≥40 from 2010 onwards were located for 18 individual countries, on all five continents, comprising 12% of eligible national survey data examined ( Table 2 ) either in its primary form (n = 10) or through secondary analysis (n = 8). Data were very recent, with half of the countries reporting prevalence from 2015 onwards, and only three back to 2010. None of the original sources located reported BMI data categories higher than BMI ≥40
(for example, BMI ≥45/≥50), with just one secondary analysis from Spain doing so. 41 Germany, 37 Saudi Arabia, 43 Seychelles, 46 and Poland 38 report only for men and women separately, with no data for combined-sex adults. In contrast, only combined-sex-adult data were available for Brazil 48 and Portugal. 39 All regions of the world (as defined by WHO) contained a country with rates above 4% for women, and 2% for men, with the exception of Africa, where the maximum was Seychelles with 1.5% for men. 46 Other than Brunei Darussalam, 51 rates for women were universally higher than for men.
Prevalence rates are presented graphically in Figure 2A -C. The
United States has the highest prevalence, 49 with rates across all adults, men, and women ranging between 5.6% and 9.7%. Other countries with higher rates (5.0%-7.7%) for all adults and women are New Zealand, 45 Kuwait, 42 and Barbados, 47 although rates in men are markedly lower. Australia, 44 Canada, 50 Scotland, 36 England, 35 and Saudi Arabia all have rates in the region of 2.5% to 5.5% for all adults and/or women, again with men notably lower. Germany, Serbia, 40 Spain, Portugal, Poland, Brazil, and Malaysia 52 display the lowest rates between 0.7% and 2.8%. Brunei Darussalam and Seychelles both exhibit disparate prevalence patterns from those above for men and women. Table 2 .
Less than half of the countries included have regular surveillance, ranging from annual to three to four yearly ( Table 2: England, Scotland, Canada, New Zealand, Australia, and the United States), significantly limiting analysis of trends over time. Reporting from other countries appears to be more ad hoc and unpredictable, without planning for regular surveillance. 
| International survey data sources

| Data quality
To enable assessment of data quality, the column headers of Table 2 highlight basic quality parameters appropriate to national health surveillance, 58 Data collection methods of included surveys were scrutinized for factors that may affect participation of people with BMI ≥40
( Table 2) . Eleven countries specifically stated exclusion criteria, which were very similar, namely, the institutionalized population.
This excluded those in hospitals and, apart from New Zealand, people in care homes. No surveys appeared to document an upper BMI limit, but the capacity of scales used has potential to enact this, effectively meaning individuals with weights over the maximum capacity of the instrument are either excluded or estimated self-reports. 35 60 Australia saw similar increases of 2.9-fold for men and 2.0-fold for women between 1995 and 2011 to 2012. 61 Prevalence of BMI ≥40 in the United States quadrupled between 1976 and 2004, substantially surpassing the rise in BMI ≥30. 62 Prevalence in men in England aged 16 years or older experienced an eight-fold increase since 1995, 35 but Brazil reported the most dramatic increase of nearly 20-fold between 1974-1975 and 2013. 48 Overall population distributions have thus consistently shifted upwards, as illustrated in Figure 3 , comparing waves of US NHANES data from 1967-1980 to 2005-2006. 63 Comparison with analyses of self-report surveys from the United States and Canada, which allow for much larger samples, all show disproportionately larger growth in higher BMI categories, with increases of up to 10-fold in the BMI ≥40 category. [64] [65] [66] This is despite suggestions that the underestimation of weight for self-report data is likely to be greater with higher BMI. 31 Thus, despite wide confidence intervals in individual survey years and some variations in methodologies, measured trend data evidence from several countries, together with larger-scale self-report datasets, all support a long-term rise in BMI ≥40.
Two key sources of data for NCD-RisC and WOF were STEPS reports and Demographic Health Survey (DHS) country reports.
The STEPwise approach, featuring three different level of "steps"
of key risk factor assessments for NCDs, was developed by WHO, to aid countries increase their surveillance capacity. 67 One hundred and thirteen country reports or data sheets were publicly available on the WHO STEPS site at the time of searching. 68 International health surveillance provides reliable health information that is comparable over time and between populations. It has allowed documentation of a nutrition transition that is rooted in the impact of large-scale social changes such as reduction in physical activity, increased urbanization, and greater consumption of processed food. 70 Whilst regional variation remains, the major global concern has moved away from underweight as the primary nutrition issue, towards excess weight as the leading cause of morbidity and mortality through secondary noncommunicable diseases. 23 This has already occurred to such a degree that BMI ≥35
in women now surpasses underweight in 165 countries for women and 113 for men. 3 42, 66 Without characterizing this progression, policymakers and planners are unable to respond effectively to the needs of the population or evaluate the effectiveness of policies.
The example of Kuwait in this review provides a case in point.
The original 2014 STEPS report on the WHO website documents the mean BMI and four separate BMI categories <18.5, 18.5 to 24.9, 25.0 to 29.9, and ≥30, without ≥40, as a distinct category. 68 The BMI ≥40 data were later reported by the analysis of Weiderpass et al of the original STEPS dataset, illustrating that the data had been collected but gone unreported. 42 Table 2 shows
Kuwait's prevalence rates as second highest only to the United States, providing valuable information regarding BMI population distribution, in a region where no other sources of all adult prevalence were found.
One practical solution would be for WHO and similar agencies to call for data on the BMI ≥40 population to be included when reporting all anthropometry surveys. The National Child Measurement Programme in England took an equivalent step in 2018, adding severe obesity as a reporting category. 71 Given that the prevalence of BMI ≥50 is now similar to that of the BMI ≥40 category about 20 years ago, with some real-world datasets including categories of 50/60/70, 72 it may be wise also to include reporting BMI ≥50, to map future trends. This would hugely increase the amount of BMI ≥40 data available globally, with little extra cost,
given that the data are already collected. For countries with small numbers to report, the need for caution in interpretation would be dealt with in the same way for low numbers in any category, for example, underweight.
| Causation
The lack of data on BMI ≥40 trajectories by region, nation, age, sex, and class makes it difficult to explore causation. Improved international data, ideally from longitudinal studies, would promote comparison between countries, taking into account their differing social and economic contexts. 73 Together with the emergence of large-scale genome studies looking at the inherited susceptibility to BMI ≥40, 74 reasons for the escalation of high body weight may be more accurately sought. There are some indications of associations with lower socio-economic status in some populations, 75, 76 but these patterns require further study. Concerningly, some countries report increasing rates of the highest BMI groups growing for children and adolescents, 71, 77 with potential for excess weight to track through into adulthood. This would differ from current patterns, when rates are lower in early adulthood, peaking in middle age. 35, 49, 78 Unusually, the survey data from Brunei Darussalam showed 19-to 29-year-olds having some of the highest rates of BMI ≥40 across the age trajectory. 51 A lack of prevalence data keeps the population hidden, preventing development of appropriate weight management services to treat this population group, along with comparative analysis of different treatment models and health care systems. 25 BMI ≥35 with comorbidities or BMI ≥40 with or without comorbidities is a commonly applied threshold for bariatric surgery, yet access to surgery is often very limited. 19, 79 Evidence on effective alternatives to surgery or prevention is needed, whilst access to traditional services can be difficult for people with BMI ≥40 due to functional disability. 80 Improved global prevalence data would facilitate work on economic costing of treatment and prevention for the population with BMI ≥40.
| Consequences of rise in prevalence
Whilst numbers may appear small in terms of proportion of the whole population, given that these are at national scale, they translate into significant absolute numbers with a large real-life impact on care provision.
| Health risk and comorbidities
It is well recognized that BMI can be a poor proxy for body fat, and in many studies, waist circumference or evidence-based predictive equations for total body fat are better than BMI for assessing health risk, particularly cardiac and metabolic health outcomes. [81] [82] [83] [84] Consequently 86 to seven times, 40 particularly for cardiometabolic multimorbidity. 22 Alongside physical diseases, risk of depression increases with BMI, 87 together with functional disability, 88 with increasing numbers of people with BMI ≥40 living in care homes. 29 As such care of these multiple obesityrelated consequences amplifies health care costs considerably. 89 Given the rise in prevalence and size of these costs, in addition to older costing studies being limited by BMI thresholds that are now too low, this is likely to become of increasing concern globally.
| Planning
As an emerging population, people with BMI ≥40, especially those with BMI ≥50 and ≥60, have needs that are currently often unaddressed by service providers. 4 
| Strengths and limitations
This review has concentrated on robustly measured data to establish the international prevalence rates for BMI ≥40. Whilst the rationale for exclusion of self-report data is sound, in that it commonly underestimates BMI, the exclusion also acts as a limitation, for example, by excluding EHIS data, which covers many European countries. The sample sizes possible with measured data are reduced by the need for resources to make measurements, and there is potential bias against including very heavy individuals whose mobility is impaired. In some cases, the upper limit of scales excluded the heaviest individuals. These limitations would tend to underestimate the true prevalence of the highest BMI categories, not overestimate.
Applying a lower threshold of BMI ≥35 would have broadened the available data, whilst potentially weakening the focus on the highest BMI category, where costs and clinical complexity is greatest.
Some studies report the lower threshold of BMI ≥35 particularly those examining Asian populations where different BMI cut-offs relating to overweight and obesity are often applied. 98 Limiting the review to the English language prevented examination of some original data sources, which could only be located in their native language, for example, Spanish for Chile and Mexico. It was not possible to locate English versions of these, and resources did not allow for translation. The OECD reports these original sources in English in its database, but only at BMI thresholds of 25.0 to 29.9
and BMI ≥30, with prevalence for Chile and Mexico the highest in the world, above even those of the United States. 99 Thus, they are likely to have significant BMI ≥40 prevalence. Additionally, whilst the search processes were broad, encompassing a variety of sources and used systematic methods, they were not exhaustive, as might be expected from a formal systematic literature review or meta-analysis.
We believe that they represent a reliable summary of the current evidence base on BMI ≥40, as it is available to decision makers. Some individual sources have not been included, notably those from non-English publications, but they are unlikely to alter the very consistent conclusions. 
| CONCLUSION
